{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:29:25Z","timestamp":1783247365967,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171544"],"award-info":[{"award-number":["82171544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971251"],"award-info":[{"award-number":["81971251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871050"],"award-info":[{"award-number":["81871050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019330","name":"Shanghai Clinical Research Center for Mental Health","doi-asserted-by":"publisher","award":["19MC1911100"],"award-info":[{"award-number":["19MC1911100"]}],"id":[{"id":"10.13039\/501100019330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Center at Shanghai Jiaotong University School of Medicine","award":["DLY201817"],"award-info":[{"award-number":["DLY201817"]}]},{"name":"Clinical Research Center at Shanghai Jiaotong University School of Medicine","award":["20190102"],"award-info":[{"award-number":["20190102"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["No.2018SHZDZX01"],"award-info":[{"award-number":["No.2018SHZDZX01"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["2018SHZDZX05"],"award-info":[{"award-number":["2018SHZDZX05"]}]},{"name":"Clinical Research Plan of SHDC","award":["CRC2018ZD01"],"award-info":[{"award-number":["CRC2018ZD01"]}]},{"name":"Clinical Research Plan of SHDC","award":["CRC2018ZD04"],"award-info":[{"award-number":["CRC2018ZD04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00406-023-01556-3","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T06:02:57Z","timestamp":1674453777000},"page":"1725-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Attenuated niacin response is associated with a subtype of first-episode drug-na\u00efve psychosis characterized as serious negative symptoms"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-7119","authenticated-orcid":false,"given":"TianHong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RanPiao","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaHui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaYi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YeGang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiHua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanYan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoChen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunBo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiChun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiJun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000284591","volume":"22","author":"J Andersen","year":"1989","unstructured":"Andersen J, Larsen JK, Schultz V, Nielsen BM, Korner A, Behnke K, Munk-Andersen E, Butler B, Allerup P, Bech P (1989) The brief psychiatric rating scale. Dimension of schizophrenia\u2013reliability and construct validity. Psychopathology 22:168\u2013176","journal-title":"Psychopathology"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin SF, Mors O, Budtz-Jorgensen E, Secher RG, Hjorthoj CR, Bertelsen M, Jeppesen P, Petersen L, Thorup A, Nordentoft M (2015) Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10 year follow-up study in the opus cohort. Schizophr Res 168:84\u201391","journal-title":"Schizophr Res"},{"key":"1556_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.112970","volume":"289","author":"L Baandrup","year":"2020","unstructured":"Baandrup L, Allerup P, Nielsen MO, Bak N, During SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Diaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Kahn RS, Glenthoj BY (2020) Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia\u2014data from the OPTiMiSE trial. Psychiatry Res 289:112970","journal-title":"Psychiatry Res"},{"key":"1556_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148429","volume":"11","author":"GE Berger","year":"2016","unstructured":"Berger GE, Smesny S, Schafer MR, Milleit B, Langbein K, Hipler UC, Milleit C, Klier CM, Schlogelhofer M, Holub M, Holzer I, Berk M, McGorry PD, Sauer H, Amminger GP (2016) Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis. PLoS ONE 11:e0148429","journal-title":"PLoS ONE"},{"key":"1556_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/schbul\/sbm153","volume":"35","author":"SS Chang","year":"2009","unstructured":"Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK, Hsieh MH, Guo SC, Chen WJ (2009) Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophr Bull 35:213\u2013221","journal-title":"Schizophr Bull"},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/schbul\/sby115","volume":"45","author":"WC Chang","year":"2019","unstructured":"Chang WC, Ho RWH, Tang JYM, Wong CSM, Hui CLM, Chan SKW, Lee EMH, Suen YN, Chen EYH (2019) Early-stage negative symptom trajectories and relationships with 13-year outcomes in first-episode nonaffective psychosis. Schizophr Bull 45:610\u2013619","journal-title":"Schizophr Bull"},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","volume":"159","author":"R Emsley","year":"2002","unstructured":"Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ (2002) Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159:1596\u20131598","journal-title":"Am J Psychiatry"},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.eurpsy.2014.01.007","volume":"29","author":"G Fervaha","year":"2014","unstructured":"Fervaha G, Foussias G, Agid O, Remington G (2014) Impact of primary negative symptoms on functional outcomes in schizophrenia. Eur Psychiatry 29:449\u2013455","journal-title":"Eur Psychiatry"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamapsychiatry.2017.4607","volume":"75","author":"S Galderisi","year":"2018","unstructured":"Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell\u2019Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M, Italian Network for Research on P (2018) Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiat 75:396\u2013404","journal-title":"JAMA Psychiat"},{"key":"1556_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","volume":"55","author":"AI Glen","year":"1996","unstructured":"Glen AI, Cooper SJ, Rybakowski J, Vaddadi K, Brayshaw N, Horrobin DF (1996) Membrane fatty acids, niacin flushing and clinical parameters. Prostagland Leukot Essent Fatty Acids 55:9\u201315","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40263-015-0308-1","volume":"30","author":"RC Harvey","year":"2016","unstructured":"Harvey RC, James AC, Shields GE (2016) A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia. CNS Drugs 30:27\u201339","journal-title":"CNS Drugs"},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/schbul\/sbj009","volume":"32","author":"WP Horan","year":"2006","unstructured":"Horan WP, Kring AM, Blanchard JJ (2006) Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 32:259\u2013273","journal-title":"Schizophr Bull"},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","volume":"30","author":"DF Horrobin","year":"1998","unstructured":"Horrobin DF (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30:193\u2013208","journal-title":"Schizophr Res"},{"key":"1556_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","volume":"13","author":"DF Horrobin","year":"1994","unstructured":"Horrobin DF, Glen AI, Vaddadi K (1994) The membrane hypothesis of schizophrenia. Schizophr Res 13:195\u2013207","journal-title":"Schizophr Res"},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.schres.2021.06.028","volume":"243","author":"Y Hu","year":"2021","unstructured":"Hu Y, Xu L, Gan R, Wu G, Tang X, Wei Y, Cui H, Hui L, Tang Y, Li C, Chen T, Wan C, Wang J, Zhang T (2021) A potential objective marker in first-episode schizophrenia based on abnormal niacin response. Schizophr Res 243:405","journal-title":"Schizophr Res"},{"key":"1556_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","volume":"41","author":"CJ Hudson","year":"1997","unstructured":"Hudson CJ, Lin A, Cogan S, Cashman F, Warsh JJ (1997) The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry 41:507\u2013513","journal-title":"Biol Psychiatry"},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5539\/gjhs.v6n7p103","volume":"6","author":"H Jamilian","year":"2014","unstructured":"Jamilian H, Solhi H, Jamilian M (2014) Randomized, placebo-controlled clinical trial of omega-3 as supplemental treatment in schizophrenia. Glob J Health Sci 6:103\u2013108","journal-title":"Glob J Health Sci"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/schbul\/16.3.537","volume":"16","author":"SR Kay","year":"1990","unstructured":"Kay SR, Sevy S (1990) Pyramidical model of schizophrenia. Schizophr Bull 16:537\u2013545","journal-title":"Schizophr Bull"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1176\/ajp.156.3.406","volume":"156","author":"ME Kelley","year":"1999","unstructured":"Kelley ME, van Kammen DP, Allen DN (1999) Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am J Psychiatry 156:406\u2013411","journal-title":"Am J Psychiatry"},{"key":"1556_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/sjop.12017","volume":"54","author":"J Langeveld","year":"2013","unstructured":"Langeveld J, Andreassen OA, Auestad B, Faerden A, Hauge LJ, Joa I, Johannessen JO, Melle I, Rund BR, Rossberg JI, Simonsen E, Vaglum P, Larsen TK (2013) Is there an optimal factor structure of the positive and negative syndrome scale in patients with first-episode psychosis? Scand J Psychol 54:160\u2013165","journal-title":"Scand J Psychol"},{"issue":"Suppl","key":"1556_CR22","first-page":"S163","volume":"31","author":"JD Laugharne","year":"1996","unstructured":"Laugharne JD, Mellor JE, Peet M (1996) Fatty acids and schizophrenia. Lipids 31(Suppl):S163-165","journal-title":"Lipids"},{"issue":"Suppl 1","key":"1556_CR23","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM (2016) Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull 42(Suppl 1):S90-94","journal-title":"Schizophr Bull"},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.schres.2014.04.005","volume":"156","author":"SZ Levine","year":"2014","unstructured":"Levine SZ, Leucht S (2014) Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials. Schizophr Res 156:107\u2013114","journal-title":"Schizophr Res"},{"key":"1556_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.psychres.2006.10.002","volume":"152","author":"CM Liu","year":"2007","unstructured":"Liu CM, Chang SS, Liao SC, Hwang TJ, Shieh MH, Liu SK, Chen WJ, Hwu HG (2007) Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Psychiatry Res 152:181\u2013187","journal-title":"Psychiatry Res"},{"key":"1556_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0278-5846(03)00152-0","volume":"27","author":"R Maclean","year":"2003","unstructured":"Maclean R, Ward PE, Glen I, Roberts SJ, Ross BM (2003) On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis. Prog Neuropsychopharmacol Biol Psychiatry 27:927\u2013933","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/wps.20385","volume":"16","author":"SR Marder","year":"2017","unstructured":"Marder SR, Galderisi S (2017) The current conceptualization of negative symptoms in schizophrenia. World Psychiatry 16:14\u201324","journal-title":"World Psychiatry"},{"key":"1556_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s10618-013-0320-3","volume":"28","author":"D Mavroeidis","year":"2014","unstructured":"Mavroeidis D, Marchiori E (2014) Feature selection for k-means clustering stability: theoretical analysis and an algorithm. Data Min Knowl Disc 28:918\u2013960","journal-title":"Data Min Knowl Disc"},{"key":"1556_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.schres.2012.03.001","volume":"137","author":"E Messamore","year":"2012","unstructured":"Messamore E (2012) Niacin subsensitivity is associated with functional impairment in schizophrenia. Schizophr Res 137:180\u2013184","journal-title":"Schizophr Res"},{"key":"1556_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","volume":"62","author":"E Messamore","year":"2003","unstructured":"Messamore E, Hoffman WF, Janowsky A (2003) The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res 62:251\u2013258","journal-title":"Schizophr Res"},{"key":"1556_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","volume":"122","author":"E Messamore","year":"2010","unstructured":"Messamore E, Hoffman WF, Yao JK (2010) Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res 122:248\u2013256","journal-title":"Schizophr Res"},{"key":"1556_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0163-7827(03)00037-7","volume":"43","author":"M Murakami","year":"2004","unstructured":"Murakami M, Kudo I (2004) Recent advances in molecular biology and physiology of the prostaglandin e2-biosynthetic pathway. Prog Lipid Res 43:3\u201335","journal-title":"Prog Lipid Res"},{"key":"1556_CR33","first-page":"14","volume":"22","author":"S Nadalin","year":"2010","unstructured":"Nadalin S, Buretic-Tomljanovic A, Rubesa G, Tomljanovic D, Gudelj L (2010) Niacin skin flush test: a research tool for studying schizophrenia. Psychiatr Danub 22:14\u201327","journal-title":"Psychiatr Danub"},{"key":"1556_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.plefa.2012.11.005","volume":"88","author":"S Nadalin","year":"2013","unstructured":"Nadalin S, Giacometti J, Jonovska S, Tomljanovic D, Buretic-Tomljanovic A (2013) The impact of pla2g4a and ptgs2 gene polymorphisms, and red blood cell pufas deficit on niacin skin flush response in schizophrenia patients. Prostagland Leukot Essent Fatty Acids 88:185\u2013190","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.plefa.2006.02.002","volume":"74","author":"BM Nilsson","year":"2006","unstructured":"Nilsson BM, Hultman CM, Wiesel FA (2006) Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls. Prostagland Leukot Essent Fatty Acids 74:339\u2013346","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR36","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1172\/JCI27160","volume":"115","author":"NB Pike","year":"2005","unstructured":"Pike NB (2005) Flushing out the role of gpr109a (hm74a) in the clinical efficacy of nicotinic acid. J Clin Invest 115:3400\u20133403","journal-title":"J Clin Invest"},{"key":"1556_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plefa.2007.07.002","volume":"77","author":"BK Puri","year":"2007","unstructured":"Puri BK, Richardson AJ, Counsell SJ, Ward PE, Bustos MG, Hamilton G, Bhakoo KK, Treasaden IH (2007) Negative correlation between cerebral inorganic phosphate and the volumetric niacin response in male patients with schizophrenia who have seriously and dangerously violently offended: a (31)p magnetic resonance spectroscopy study. Prostagland Leukot Essent Fatty Acids 77:97\u201399","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.plefa.2017.05.002","volume":"136","author":"BM Ross","year":"2018","unstructured":"Ross BM (2018) Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: a preliminary investigation. Prostagland Leukot Essent Fatty Acids 136:99\u2013102","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR39","doi-asserted-by":"crossref","unstructured":"Salagre E, Grande I, Vieta E, Mezquida G, Cuesta MJ, Moreno C, Bioque M, Lobo A, Gonzalez-Pinto A, Moreno DM, Corripio I, Verdolini N, Castro-Fornieles J, Mane A, Pinzon-Espinosa J, Bonnin CDM, Bernardo M, Group P (2020) Predictors of bipolar disorder versus schizophrenia diagnosis in a multicenter first psychotic episode cohort: Baseline characterization and a 12-month follow-up analysis. J Clin Psychiatry 81","DOI":"10.4088\/JCP.19m12996"},{"key":"1556_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.plefa.2010.07.001","volume":"83","author":"MM Sethom","year":"2010","unstructured":"Sethom MM, Fares S, Bouaziz N, Melki W, Jemaa R, Feki M, Hechmi Z, Kaabachi N (2010) Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. Prostagland Leukot Essent Fatty Acids 83:131\u2013136","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR41","first-page":"163","volume":"43","author":"SH Shah","year":"2000","unstructured":"Shah SH, Vankar GK, Peet M, Ramchand CN (2000) Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin. Schizophr Res 43:163\u2013164","journal-title":"Schizophr Res"},{"key":"1556_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","volume":"37","author":"S Smesny","year":"2003","unstructured":"Smesny S, Berger G, Rosburg T, Riemann S, Riehemann S, McGorry P, Sauer H (2003) Potential use of the topical niacin skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res 37:237\u2013247","journal-title":"J Psychiatr Res"},{"key":"1556_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.plefa.2007.08.006","volume":"77","author":"S Smesny","year":"2007","unstructured":"Smesny S, Klemm S, Stockebrand M, Grunwald S, Gerhard UJ, Rosburg T, Sauer H, Blanz B (2007) Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia. Prostagland Leukot Essent Fatty Acids 77:79\u201385","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR44","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/sj.npp.1301343","volume":"32","author":"S Smesny","year":"2007","unstructured":"Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H (2007) Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. Neuropsychopharmacology 32:2067\u20132073","journal-title":"Neuropsychopharmacology"},{"key":"1556_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","volume":"38","author":"S Smesny","year":"2004","unstructured":"Smesny S, Rosburg T, Klemm S, Riemann S, Baur K, Rudolph N, Grunwald S, Sauer H (2004) The influence of age and gender on niacin skin test results\u2014implications for the use as a biochemical marker in schizophrenia. J Psychiatr Res 38:537\u2013543","journal-title":"J Psychiatr Res"},{"key":"1556_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","volume":"72","author":"S Smesny","year":"2005","unstructured":"Smesny S, Rosburg T, Riemann S, Baur K, Rudolph N, Berger G, Sauer H (2005) Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostagland Leukot Essent Fatty Acids 72:393\u2013402","journal-title":"Prostagland Leukot Essent Fatty Acids"},{"key":"1556_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/schbul\/sbx150","volume":"44","author":"L Sun","year":"2018","unstructured":"Sun L, Yang X, Jiang J, Hu X, Qing Y, Wang D, Yang T, Yang C, Zhang J, Yang P, Wang P, Cai C, Wang J, He L, Wan C (2018) Identification of the niacin-blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population. Schizophr Bull 44:896\u2013907","journal-title":"Schizophr Bull"},{"key":"1556_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2006.04.051","volume":"345","author":"Y Tang","year":"2006","unstructured":"Tang Y, Zhou L, Gunnet JW, Wines PG, Cryan EV, Demarest KT (2006) Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor hm74a. Biochem Biophys Res Commun 345:29\u201337","journal-title":"Biochem Biophys Res Commun"},{"key":"1556_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","volume":"61","author":"H Tavares","year":"2003","unstructured":"Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF (2003) Increased phospholipase a2 activity in schizophrenia with absent response to niacin. Schizophr Res 61:1\u20136","journal-title":"Schizophr Res"},{"key":"1556_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","volume":"230","author":"DD Wang","year":"2021","unstructured":"Wang DD, Hu XW, Jiang J, Sun LY, Qing Y, Yang XH, Gao Y, Cui GP, Li MH, Wang PK, Zhang J, Zhuang Y, Li ZZ, Li J, Guan LL, Zhang TH, Wang JJ, Ji F, Wan CL (2021) Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: a potential clinical auxiliary diagnostic marker. Schizophr Res 230:53\u201360","journal-title":"Schizophr Res"},{"key":"1556_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/schbul\/sbv130","volume":"42","author":"JK Yao","year":"2016","unstructured":"Yao JK, Dougherty GG Jr, Gautier CH, Haas GL, Condray R, Kasckow JW, Kisslinger BL, Gurklis JA, Messamore E (2016) Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia. Schizophr Bull 42:369\u2013376","journal-title":"Schizophr Bull"},{"key":"1556_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41537-022-00252-w","volume":"8","author":"YH Yu","year":"2022","unstructured":"Yu YH, Su HM, Lin SH, Hsiao PC, Lin YT, Liu CM, Hwang TJ, Hsieh MH, Liu CC, Chien YL, Kuo CJ, Hwu HG, Chen WJ (2022) Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship. Schizophrenia (Heidelb) 8:38","journal-title":"Schizophrenia (Heidelb)"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01556-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:05:09Z","timestamp":1702321509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01556-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}